INFeD® improved the hemoglobin response to erythropoietic therapy in have been reported after administration of iron dextran injection, the drug should be. iron dextran – Drug Summary. Jump to INFeD Intramuscular Inj Sol: 1mL, 50mg . INFeD: INFeD is administered by intramuscular or intravenous injection. Allergan, Inc.: Intravenous or intramuscular injections of INFeD are indicated for treatment of patients with documented iron deficiency in whom.

Author: Faurg Shakazuru
Country: Ecuador
Language: English (Spanish)
Genre: History
Published (Last): 7 August 2014
Pages: 227
PDF File Size: 17.8 Mb
ePub File Size: 3.98 Mb
ISBN: 112-8-39901-769-7
Downloads: 54181
Price: Free* [*Free Regsitration Required]
Uploader: Maujar

Therefore, the therapeutic prescription use of iron is usually compatible with breast-feeding if the lactating mother needs treatment for iron deficiency. Iron dextran is not FDA-approved to be administered as a total dose infusion.

We do not record any personal information entered above. Patients using beta-blocking agents may not respond adequately to epinephrine. Periodic hematologic determination hemoglobin and hematocrit is a simple and accurate technique for monitoring hematological response, and should be used as a guide in therapy.

A therapeutic response to treatment with iron products is dependent on the patient’s ability to absorb and use the iron, and it is influenced by the cause of the deficiency as well as other illnesses that can affect normal erythropoiesis.

Infusion should then be stopped for 1 hour. Ferric iron is then gradually released into lnfed plasma where it combines rapidly with transferrin. Although anaphylactic reactions known to occur following INFeD administration are usually evident within a few minutes, or sooner, it is recommended that a period of an hour or longer elapse before the remainder jnfed the initial therapeutic dose is given. Transferrin delivers iron to specific receptors for deposit, where it is pckage incorporated into hemoglobin or oxidized and stored in combination with apoferritin as ferritin.

Iron dextran (INFeD) | – A Hematology Oncology Wiki

Alternatively the total dose may be calculated:. Too much iron can be toxic, and iron is not easily eliminated from the body. Facilities for cardiopulmonary resuscitation and personnel trained in the detection and treatment of anaphylactoid reactions must inxert available during administration. Once taken into reticuloendothelial cells, the iron from the iron dextran complex is separated and added to the body’s total iron stores.


Iron therapy in these patients should be directed toward replacement of the equivalent amount of iron represented in the blood loss. Non-iron deficient animal data rats, mice, dogs and monkeys reveal that iron dextran crosses the placenta.

Normal erythropoiesis is dependent on the concentration of iron and erythropoietin available in the plasma. There are no adequate and well-controlled studies in pregnant women. The total amount of INFeD in mL required to treat the anemia and replenish iron stores may be approximated as follows:. Do not administer iron during dimercaprol treatment. Following intramuscular injection pwckage iron dextran, the drug is slowly absorbed in two stages primarily through the lymphatic system.

PDR Search

Therefore, administration of subsequent test doses during therapy should be considered. Intermittent hemodialysis Before supplementing hemodialysis patients with iron dextran, a diagnosis of absolute or functional iron deficiency should be made. Administer supplemental iron therapy when serum ferritin is Fosinopril: Iron stores are utilized in erythropoiesis and can be depleted during therapy even in patients with normal infwd iron concentrations.

Such iron overload is particularly apt to occur in patients with hemoglobinopathies and other refractory anemias that might be erroneously diagnosed as iron deficiency anemias. Before administering therapeutic doses by any route, a test dose of 25 mg 0. DexFerrum is administered by packaage injection only. Fatal anaphylactic reactions are possible.

Most patients with chronic kidney disease will require supplemental iron e. Infants 4 months and older weighing less than 5 kg. Minor Iron stores should be replete before and during treatment with an ESA. Some patients with chronic hepatic disease may also have hemochromatosis or moderate iron overload in hepatic tissues. Before administering therapeutic doses, a test dose of 25 mg 0. Each 1 mL of iron dextran injection contains 50 mg of elemental iron. Major Parenteral iron formulas are generally only indicated for use in patients with documented iron deficiency in whom oral administration is either impossible or unsatisfactory.


The liver is one of the main storage sites for iron, and some patients with chronic liver disease may have excessive iron storage.

Iron dextran (INFeD)

There is packaage concern that intravenously administered iron is not used appropriately by the body. This total iron requirement reflects the amount of iron needed to restore hemoglobin concentration to normal or near normal levels plus an additional allowance to provide adequate replenishment of iron stores in most individuals with moderately or severely reduced levels of hemoglobin.

Periodic monitoring of serum ferritin levels may be helpful in recognizing a progressive accumulation of iron resulting from impaired iron uptake from the reticuloendothelial system in patients with renal failure. Severe Dimercaprol forms toxic chelates with iron. Iron dextran is contraindicated in patients with iron dextran hypersensitivity.

Therapy, thus, should aim at not only replenishment of hemoglobin iron but iron stores as well. A test dose should be given prior to administration of the initial therapeutic dose. If test dose uneventful, give the remainder of the total dose as mg elemental iron per day IM or IV until the total calculated dose is given. However, iron deficiency may develop, especially in children and menstruating or pregnant women, or as a result of the low copper diet recommended for Wilson’s disease.

Do not administer iron dextran to patients with evidence of iron overload e. Minor Inadequate iron stores will interfere with the therapeutic response to epoetin alfa e.

Author: admin